Literature DB >> 24721243

[Meta-analysis of branched chain amino acid-enriched nutrition to improve hepatic function in patients undergoing hepatic operation].

Xiaoliang Shu1, Kai Kang, Jingxia Zhong, Shurong Ji, Yongsheng Zhang, Huaidong Hu, Dazhi Zhang.   

Abstract

OBJECTIVE: To perform a meta-analysis of randomized controlled trials (RCTs) assessing the benefit of providing branched chain amino acid (BCAA)-enriched nutrition to improve hepatic function in patients undergoing hepatic operation.
METHODS: The electronic databases of PubMed, Springerlink, the Chinese Biomedical Database (CBM), the Cochrane Library, and the China National Knowledge Infrastructure (CNKI) were searched for relevant RCTs using the following search terms: nutritional support, enteral nutrition, parenteral nutrition, hepatic/liver surgery, liver cirrhosis, cancer, hepatectomy, and liver transplantation. The quality of the retrieved RCTs was assessed according to the scale developed by the Cochrane Collaboration. The meta-analysis was conducted using RevMan software, version 5.2.
RESULTS: A total of 11 relevant RCTs, representing 510 patients, were included in the meta-analysis. Compared to patients in the control (normal nutrition) group, the patients in the BCAA group experienced an effective improvement in hepatic function, as evidenced by significant decreases in total bilirubin (by 0.07 mumol/L; 95% confidence interval (CI): -0.18 to 0.05, P more than 0.05]. In addition, the BCAA group showed improvements in plasma levels of albumin (weighted mean difference (WMD) = 0.07; 95% CI: 0.06, 0.24, P less than 0.05) and alanine aminotransferase (WMD = +5.61; 95% CI: -8.63 to 19.86, P more than 0.05] but neither of the changes reached the threshold of a statistically significant improvement. The BCAA group did however show significantly lower complication rate after operation (65%, 95% CI: 0.48, 0.87, P less than 0.01] and mean duration of hospital stay (4.61 days; 95% CI: -6.61, -2.61, P less than 0.01].
CONCLUSION: BCAA-enriched nutrition improves hepatic function in patients undergoing hepatic operation, thereby helping to reduce the complication risk, duration of hospital stay, and financial burden. BCAA-enriched nutrition is a safe and effective therapy and further clinical application may be beneficial.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24721243     DOI: 10.3760/cma.j.issn.1007-3418.2014.01.010

Source DB:  PubMed          Journal:  Zhonghua Gan Zang Bing Za Zhi        ISSN: 1007-3418


  4 in total

1.  Short-term Outcomes of Laparoscopic vs. Open Hepatectomy for Primary Hepatocellular Carcinoma: A Prospective Comparative Study.

Authors:  Li Zeng; Min Tian; Si-Si Chen; Yu-Ting Ke; Li Geng; Sheng-Li Yang; Lin Ye
Journal:  Curr Med Sci       Date:  2019-10-14

Review 2.  Nutrition therapy: Integral part of liver transplant care.

Authors:  Lucilene Rezende Anastácio; Maria Isabel Toulson Davisson Correia
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

Review 3.  Efficacy and safety of oral branched-chain amino acid supplementation in patients undergoing interventions for hepatocellular carcinoma: a meta-analysis.

Authors:  Ling Chen; Yaqin Chen; Xiwei Wang; Hong Li; Hongmin Zhang; Jiaojiao Gong; Shasha Shen; Wenwei Yin; Huaidong Hu
Journal:  Nutr J       Date:  2015-07-09       Impact factor: 3.271

4.  Consumption of a Branched-Chain Amino Acid (BCAA) during Days 2-10 of Pregnancy Causes Abnormal Fetal and Placental Growth: Implications for BCAA Supplementation in Humans.

Authors:  Chiu Yuen To; Muriel Freeman; Lon J Van Winkle
Journal:  Int J Environ Res Public Health       Date:  2020-04-03       Impact factor: 3.390

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.